Nikhil Hebbar

558 total citations
19 papers, 365 citations indexed

About

Nikhil Hebbar is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Nikhil Hebbar has authored 19 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Nikhil Hebbar's work include CAR-T cell therapy research (8 papers), Cell death mechanisms and regulation (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Nikhil Hebbar is often cited by papers focused on CAR-T cell therapy research (8 papers), Cell death mechanisms and regulation (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Nikhil Hebbar collaborates with scholars based in United States and Japan. Nikhil Hebbar's co-authors include Vivek M. Rangnekar, Ravshan Burikhanov, Chi Wang, Shirley Qiu, Nidhi Shukla, David S. Watt, Mireya Paulina Velasquez, Yanming Zhao, Abishek Vaidya and Sujuan Huang and has published in prestigious journals such as Nature Communications, Blood and Cancer Cell.

In The Last Decade

Nikhil Hebbar

18 papers receiving 363 citations

Peers

Nikhil Hebbar

ONCOL

IMMUN

EPIDE

Brittany C. Lipchick United States

И. А. Замулаева Russia

Arnhild Grothey United Kingdom

Kamila Wolanin Poland

Delphi Van Haver Belgium

Chunwan Lu United States

Samantha S. Dykes United States

Huihong You United States

Ayşegül Sapmaz Netherlands

Anastasia R. Goloudina France

Brittany C. Lipchick United States

Nikhil Hebbar

380 ×1.5

100 ×0.8

ONCOL

52 ×0.5

87 ×1.4

IMMUN

46 ×0.9

EPIDE

Citations per year, relative to Nikhil Hebbar Nikhil Hebbar (= 1×) peers Brittany C. Lipchick

Countries citing papers authored by Nikhil Hebbar

Since Specialization

Citations

This map shows the geographic impact of Nikhil Hebbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikhil Hebbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikhil Hebbar more than expected).

Fields of papers citing papers by Nikhil Hebbar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikhil Hebbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikhil Hebbar. The network helps show where Nikhil Hebbar may publish in the future.

Co-authorship network of co-authors of Nikhil Hebbar

This figure shows the co-authorship network connecting the top 25 collaborators of Nikhil Hebbar. A scholar is included among the top collaborators of Nikhil Hebbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikhil Hebbar. Nikhil Hebbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Burikhanov, Ravshan, et al.. (2024). The Tumor Suppressor Par-4 Regulates Adipogenesis by Transcriptional Repression of PPARγ. Cells. 13(17). 1495–1495. 1 indexed citations

Ibañez-Vega, Jorge, Nikhil Hebbar, Zhongzhen Yi, et al.. (2024). Protocol for live-cell imaging of immune synapse formation and activation of CAR T cells against cancer cells. STAR Protocols. 5(4). 103422–103422.

Ibañez-Vega, Jorge, et al.. (2023). DIPG-34. IMMUNE SYNAPSE OPTIMIZED GRP78-SPECIFIC CAR T CELLS ELICIT AN IMPROVED ANTITUMOR RESPONSE AGAINST DIPGS. Neuro-Oncology. 25(Supplement_1). i20–i20. 1 indexed citations

Ibañez-Vega, Jorge, Nikhil Hebbar, Zhongzhen Yi, et al.. (2023). GRP78-CAR T cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. Cell Reports Medicine. 4(11). 101297–101297. 12 indexed citations

Hebbar, Nikhil, Rebecca Epperly, Abishek Vaidya, et al.. (2022). CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nature Communications. 13(1). 587–587. 66 indexed citations

Ibañez-Vega, Jorge, et al.. (2022). 231 Dysfunctional immune synapses restrain anti-DIPG activity of CAR T cells. Regular and Young Investigator Award Abstracts. A245–A245. 1 indexed citations

Vaidya, Abishek, Erin Doherty, Sujuan Huang, et al.. (2022). Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulation. Haematologica. 108(4). 1039–1052. 8 indexed citations

Hebbar, Nikhil, Rebecca Epperly, Abishek Vaidya, et al.. (2020). GRP78 Is Expressed on the Cell Surface of Pediatric AML Blasts and Can be Targeted with GRP78-CAR T Cells without Toxicity to Hematopoietic Progenitor Cells. Blood. 136(Supplement 1). 12–12. 1 indexed citations

Hebbar, Nikhil, Chunxu Qu, Hong Wang, et al.. (2020). Multi-Omic Based Antigen Discovery for the Immunotherapy of Pediatric Acute T Cell Lymphoblastic Leukemia. Blood. 136(Supplement 1). 17–18. 1 indexed citations

10.

Kim, Kyungbo, Nikhil Hebbar, Xirong Zheng, et al.. (2019). Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer. Protein Engineering Design and Selection. 32(3). 159–166. 3 indexed citations

11.

Hebbar, Nikhil, et al.. (2018). GRP78 Is a Targetable Receptor on Cancer and Stromal Cells. EBioMedicine. 33. 2–3. 22 indexed citations

12.

Hebbar, Nikhil, Ravshan Burikhanov, Nidhi Shukla, et al.. (2017). A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors. Cancer Research. 77(15). 4039–4050. 21 indexed citations

13.

Burikhanov, Ravshan, Nikhil Hebbar, Sunil K. Noothi, et al.. (2017). Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis. Cell Reports. 18(2). 508–519. 47 indexed citations

14.

Burikhanov, Ravshan, Nikhil Hebbar, Shirley Qiu, et al.. (2014). Paracrine Apoptotic Effect of p53 Mediated by Tumor Suppressor Par-4. Cell Reports. 6(2). 271–277. 28 indexed citations

15.

Burikhanov, Ravshan, Vitaliy M. Sviripa, Nikhil Hebbar, et al.. (2014). Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis. Nature Chemical Biology. 10(11). 924–926. 45 indexed citations

16.

Hebbar, Nikhil, et al.. (2014). Cancer-Selective Apoptosis by Tumor Suppressor Par-4. Advances in experimental medicine and biology. 818. 155–166. 13 indexed citations

17.

Hebbar, Nikhil, et al.. (2013). Par(−4)oxysm in Breast Cancer. Cancer Cell. 24(1). 3–5. 6 indexed citations

18.

Burikhanov, Ravshan, Shirley Qiu, Nidhi Shukla, et al.. (2012). Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4. Cancer Research. 73(2). 1011–1019. 40 indexed citations

19.

Hebbar, Nikhil, Chi Wang, & Vivek M. Rangnekar. (2012). Mechanisms of apoptosis by the tumor suppressor Par‐4. Journal of Cellular Physiology. 227(12). 3715–3721. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact